Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)
Clinical trial NCT04736485 · COMPLETED
Trial details
- NCT number
- NCT04736485
- Sponsor
- Centre Francois Baclesse
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2024-03-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.